Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jørgen Rask-Madsen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Nature Clinical Practice. Gastroenterology & Hepatology|January 5, 2008
Non-IBD and noninfectious colitisOle Haagen Nielsen, Ben Vainer, Jørgen Rask-Madsen
Scandinavian Journal of Gastroenterology|September 17, 2005
Expression of inducible nitric oxide synthase and effects of L-arginine on colonic nitric oxide production and fluid transport in patients with "minimal colitis"Anders Perner, Lars Andresen, Michel Normark, et al.
The New England Journal of Medicine|January 3, 2003
Natalizumab for active Crohn's diseaseSubrata Ghosh, Eran Goldin, Fiona H Gordon, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Nature Clinical Practice. Gastroenterology & Hepatology|January 5, 2008
Non-IBD and noninfectious colitisOle Haagen Nielsen, Ben Vainer, Jørgen Rask-Madsen
Scandinavian Journal of Gastroenterology|September 17, 2005
Expression of inducible nitric oxide synthase and effects of L-arginine on colonic nitric oxide production and fluid transport in patients with "minimal colitis"Anders Perner, Lars Andresen, Michel Normark, et al.
The New England Journal of Medicine|January 3, 2003
Natalizumab for active Crohn's diseaseSubrata Ghosh, Eran Goldin, Fiona H Gordon, et al.
Pageof 1